TOPIC CENTER
818 Articles
Updated Oct 6, 2026
Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
Manufacturing ServicesGenmab Acquires ProfoundBio, Expands into ADC Cancer Treatments
4 min read • 2 years ago -
-
-
-
-
Drug Delivery & PackagingThe World’s Most Expensive Drug Offers Hope for MLD Patients
4 min read • 2 years ago -
-
Discovery & DevelopmentModerna Broadens Horizon with Promising Trials for New Vaccines
4 min read • 2 years ago -
Regulatory & ComplianceFDA Approves New PAH Treatments: OPSYNVI® and Winrevair
4 min read • 2 years ago -
Regulatory & ComplianceFDA Rejects Regeneron’s Blood Cancer Therapy Odronextamab Pending More Data
4 min read • 2 years ago -
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
